Joint position statement on immersion pulmonary oedema and diving from the South Pacific Underwater Medicine Society (SPUMS) and the United Kingdom Diving Medical Committee (UKDMC) 2024.

IF 0.8 4区医学 Q4 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Diving and hyperbaric medicine Pub Date : 2024-12-20 DOI:10.28920/dhm54.4.344-349

Neil Banham, David Smart, Peter Wilmshurst, Simon J Mitchell, Mark S Turner, Philip Bryson

{"title":"Joint position statement on immersion pulmonary oedema and diving from the South Pacific Underwater Medicine Society (SPUMS) and the United Kingdom Diving Medical Committee (UKDMC) 2024.","authors":"Neil Banham, David Smart, Peter Wilmshurst, Simon J Mitchell, Mark S Turner, Philip Bryson","doi":"10.28920/dhm54.4.344-349","DOIUrl":null,"url":null,"abstract":"<p><p>This joint position statement (JPS) on immersion pulmonary oedema (IPO) and diving is the product of a workshop held at the 52nd Annual Scientific Meeting of the South Pacific Underwater Medicine Society (SPUMS) from 12-17 May 2024, and consultation with the United Kingdom Diving Medical Committee (UKDMC), three members of which attended the meeting. The JPS is a consensus of experts with relevant evidence cited where available. The statement reviews the nomenclature, pathophysiology, risk factors, clinical features, prehospital treatment, investigation of and the fitness for future compressed gas diving following an episode of IPO. Immersion pulmonary oedema is a life-threatening illness that requires emergency management as described in this statement. A diver with previous suspected or confirmed IPO should consult a medical practitioner experienced in diving medicine. The SPUMS and the UKDMC strongly advise against further compressed gas diving if an individual has experienced an episode of IPO.</p>","PeriodicalId":11296,"journal":{"name":"Diving and hyperbaric medicine","volume":"54 4","pages":"344-349"},"PeriodicalIF":0.8000,"publicationDate":"2024-12-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Diving and hyperbaric medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.28920/dhm54.4.344-349","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH","Score":null,"Total":0}

引用次数: 0

Abstract

This joint position statement (JPS) on immersion pulmonary oedema (IPO) and diving is the product of a workshop held at the 52nd Annual Scientific Meeting of the South Pacific Underwater Medicine Society (SPUMS) from 12-17 May 2024, and consultation with the United Kingdom Diving Medical Committee (UKDMC), three members of which attended the meeting. The JPS is a consensus of experts with relevant evidence cited where available. The statement reviews the nomenclature, pathophysiology, risk factors, clinical features, prehospital treatment, investigation of and the fitness for future compressed gas diving following an episode of IPO. Immersion pulmonary oedema is a life-threatening illness that requires emergency management as described in this statement. A diver with previous suspected or confirmed IPO should consult a medical practitioner experienced in diving medicine. The SPUMS and the UKDMC strongly advise against further compressed gas diving if an individual has experienced an episode of IPO.

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

南太平洋水下医学学会（SPUMS）和英国潜水医学委员会（UKDMC） 2024年关于浸入式肺水肿和潜水的联合立场声明。

这份关于浸入式肺水肿（IPO）和潜水的联合立场声明（JPS）是在2024年5月12日至17日举行的南太平洋水下医学学会（SPUMS）第52届年度科学会议上召开的研讨会上与英国潜水医学委员会（UKDMC）协商的产物，其中三名成员参加了会议。JPS是专家的共识，并引用了可用的相关证据。该声明回顾了术语、病理生理学、风险因素、临床特征、院前治疗、调查和未来压缩气体潜水在IPO事件后的适用性。浸润性肺水肿是一种危及生命的疾病，需要本声明所述的紧急管理。先前怀疑或确认有首次公开募股的潜水员应咨询有潜水医学经验的医生。如果个人经历过IPO， SPUMS和UKDMC强烈建议不要进一步压缩气体跳水。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

Diving and hyperbaric medicine 医学-公共卫生、环境卫生与职业卫生

CiteScore

1.70

自引率

22.20%

发文量

审稿时长

>12 weeks

期刊介绍： Diving and Hyperbaric Medicine (DHM) is the combined journal of the South Pacific Underwater Medicine Society (SPUMS) and the European Underwater and Baromedical Society (EUBS). It seeks to publish papers of high quality on all aspects of diving and hyperbaric medicine of interest to diving medical professionals, physicians of all specialties, scientists, members of the diving and hyperbaric industries, and divers. Manuscripts must be offered exclusively to Diving and Hyperbaric Medicine, unless clearly authenticated copyright exemption accompaniesthe manuscript. All manuscripts will be subject to peer review. Accepted contributions will also be subject to editing.